Characteristics, therapy and outcome in an unselected and prospectively registered cohort of patients with gastro-oesophageal cancer

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. Cancer J Clin 2011;61:69–90.
   PubMed Web of Science ®Google Scholar
• Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. Cancer J Clin 2005;55:74–108.
   PubMed Web of Science ®Google Scholar
• Chau I, Norman AR, Cunningham D, Oates J, Hawkins R, Iveson T, et al. The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma—individual patient data from 1775 patients in four randomised controlled trials. Ann Oncol 2009;20:885–91.
   PubMed Web of Science ®Google Scholar
• Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJH, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. New Engl J Med 2006;355:11–20.
   PubMed Web of Science ®Google Scholar
• Available from: http://decv.gicancer.dk/Content/Files/Dokumenter/Kliniske%20Retningslinier%202011.pdf [2013 Apr 8].
   Google Scholar
• Cunningham D, Starling N, Rao S, Iveson T, Nicolson M, Coxon F, et al. Capecitabine and oxaliplatin for advanced esophagogastric cancer. New Engl J Med 2008;358:36–46.
   PubMed Web of Science ®Google Scholar
• Van Cutsem E, Moiseyenko VM, Tjulandin S, Majlis A, Constenla M, Boni C, et al. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V325 Study Group. J Clin Oncol 2006; 24:4991–7.
   PubMed Web of Science ®Google Scholar
• Wagner AD, Unverzagt S, Grothe W, Kleber G, Grothey A, Haerting J, et al. Chemotherapy for advanced gastric cancer. Cochrane Database of Systematic Reviews [Internet]. 2010;3. Available from: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD004064/frame.html. http://onlineibrary.wiley.com/store/10.1002/14651858.CD004064.pub3/asset/CD004064.pdf?v = 1&t = h6yvrakr&s = eb034c 73ad0b25d258e38c5d54d7fa1140ffb145. [Cited 2013 June 2]
   Google Scholar
• Sateren WB, Trimble EL, Abrams J, Brawley O, Breen N, Ford L, et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 2002;20:2109–17.
   PubMed Web of Science ®Google Scholar
• Sorbye H, Pfeiffer P, Cavalli-Björkman N, Qvortrup C, Holsen MH, Wentzel-Larsen T, et al. Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients. Cancer 2009;115:4679–87.
   PubMed Web of Science ®Google Scholar
• Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry – history, content, quality and use. Danish Med Bull 1997;44:535–9.
   PubMed Web of Science ®Google Scholar
• Schonnemann KR, Jensen HA, Yilmaz M, Jensen BY, Larsen O, Pfeiffer P. Phase II study of short-time oxaliplatin, capecitabine and epirubicin (EXE) as first-line therapy in patients with non-resectable gastric cancer. Br J Cancer 2008;99:858–61.
   PubMed Web of Science ®Google Scholar
• Schonnemann KR, Yilmaz M, Bjerregaard JK, Nielsen KM, Pfeiffer P. Phase II study of biweekly cetuximab in combination with irinotecan as second-line treatment in patients with platinum-resistant gastro-oesophageal cancer. Eur J Cancer 2012;48:510–7.
   PubMed Web of Science ®Google Scholar
• Larsen IK, Småstuen M, Johannesen TB, Langmark F, Parkin DM, Bray F, et al. Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009;45:1218–31.
   PubMed Web of Science ®Google Scholar
• De Angelis R, Francisci S, Baili P, Marchesi F, Roazzi P, Belot A, et al. The EUROCARE-4 database on cancer survival in Europe: Data standardisation, quality control and methods of statistical analysis. Eur J Cancer 2009;45: 909–30.
   PubMed Web of Science ®Google Scholar
• Barchielli A, Amorosi A, Balzi D, Crocetti E, Nesi G. Long-term prognosis of gastric cancer in a European country: A population-based study in Florence (Italy). 10-year survival of cases diagnosed in 1985–1987. Eur J Cancer 2001;37:1674–80.
   PubMed Web of Science ®Google Scholar
• Hansson L-E, Ekström A-M, Bergström R, Nyrén O. Surgery for stomach cancer in a defined Swedish population: Current practices and operative results. Eur J Surg 2000;166: 787–95.
   PubMedGoogle Scholar
• Lello E, Furnes B, Edna T-H. Short and long-term survival from gastric cancer. A population-based study from a county hospital during 25 years. Acta Oncol 2007;46:308–15.
   PubMed Web of Science ®Google Scholar
• van de Poll-Franse LV, Lemmens VEPP, Roukema JA, Coebergh JWW, Nieuwenhuijzen GAP. Impact of concentration of oesophageal and gastric cardia cancer surgery on long-term population-based survival. Br J Surg 2011;98: 956–63.
   PubMed Web of Science ®Google Scholar
• Cronin-Fenton DP, Mooney MM, Clegg LX, Harlan LC. Treatment and survival in a population-based sample of patients diagnosed with gastroesophageal adenocarcinoma. World J Gastroenterol 2008;14:3165–73.
   PubMed Web of Science ®Google Scholar
• Ychou M, Boige V, Pignon JP, Conroy T, Bouche O, Lebreton G, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: An FNCLCC and FFCD multicenter phase III trial. J Clin Oncol 2011;29:1715–21.
   PubMed Web of Science ®Google Scholar
• van Hagen P, Hulshof MCCM, van Lanschot JJB, Steyerberg EW, Henegouwen MIvB, Wijnhoven BPL, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. New Engl J Med 2012;366:2074–84.
   PubMed Web of Science ®Google Scholar
• Sung Wook H, Dong Ho L, Sang Hyub L, Young Soo P, Jin Hyeok H, Jin Wook K, et al. Preoperative staging of gastric cancer by endoscopic ultrasonography and multidetector-row computed tomography. J Gastroenterol Hepatol 2010;25:512–8.
   PubMed Web of Science ®Google Scholar
• Hofheinz RD, Al-Batran SE, Ridwelski K, Gorg C, Wehle K, Birth M, et al. Population-based patterns of care in the first-line treatment of patients with advanced esophagogastric adenocarcinoma in Germany. Onkologie 2010; 33:512–8.
   PubMedGoogle Scholar
• Shitara K, Ikeda J, Kondo C, Takahari D, Ura T, Muro K, et al. Reporting patient characteristics and stratification factors in randomized trials of systemic chemotherapy for advanced gastric cancer. Gastric Cancer 2012;15: 137–43.
   PubMed Web of Science ®Google Scholar